DE69716586D1 - Gepufferte orthoesterpolymere enthaltende arzneimittel - Google Patents

Gepufferte orthoesterpolymere enthaltende arzneimittel

Info

Publication number
DE69716586D1
DE69716586D1 DE69716586T DE69716586T DE69716586D1 DE 69716586 D1 DE69716586 D1 DE 69716586D1 DE 69716586 T DE69716586 T DE 69716586T DE 69716586 T DE69716586 T DE 69716586T DE 69716586 D1 DE69716586 D1 DE 69716586D1
Authority
DE
Germany
Prior art keywords
buffered
polymers containing
medicinal products
containing medicinal
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69716586T
Other languages
English (en)
Other versions
DE69716586T2 (de
Inventor
Robert Gurny
Monia Zignani
Cyrus Tabatabay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE69716586D1 publication Critical patent/DE69716586D1/de
Application granted granted Critical
Publication of DE69716586T2 publication Critical patent/DE69716586T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
DE69716586T 1996-03-05 1997-02-26 Gepufferte orthoesterpolymere enthaltende arzneimittel Expired - Fee Related DE69716586T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96103391 1996-03-05
PCT/EP1997/000906 WO1997032606A1 (en) 1996-03-05 1997-02-26 Pharmaceutical compositions containing buffered ortho ester polymers

Publications (2)

Publication Number Publication Date
DE69716586D1 true DE69716586D1 (de) 2002-11-28
DE69716586T2 DE69716586T2 (de) 2003-07-17

Family

ID=8222532

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69716586T Expired - Fee Related DE69716586T2 (de) 1996-03-05 1997-02-26 Gepufferte orthoesterpolymere enthaltende arzneimittel

Country Status (11)

Country Link
US (1) US6440460B1 (de)
EP (1) EP0885014B1 (de)
JP (1) JP4225570B2 (de)
KR (1) KR100441821B1 (de)
AT (1) ATE226450T1 (de)
AU (1) AU722303C (de)
DE (1) DE69716586T2 (de)
DK (1) DK0885014T3 (de)
ES (1) ES2185911T3 (de)
PT (1) PT885014E (de)
WO (1) WO1997032606A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020099438A1 (en) * 1998-04-15 2002-07-25 Furst Joseph G. Irradiated stent coating
US20030040790A1 (en) 1998-04-15 2003-02-27 Furst Joseph G. Stent coating
US7967855B2 (en) 1998-07-27 2011-06-28 Icon Interventional Systems, Inc. Coated medical device
US8070796B2 (en) 1998-07-27 2011-12-06 Icon Interventional Systems, Inc. Thrombosis inhibiting graft
US7168489B2 (en) * 2001-06-11 2007-01-30 Halliburton Energy Services, Inc. Orthoester compositions and methods for reducing the viscosified treatment fluids
US8016881B2 (en) 2002-07-31 2011-09-13 Icon Interventional Systems, Inc. Sutures and surgical staples for anastamoses, wound closures, and surgical closures
ES2315526T3 (es) * 2002-09-09 2009-04-01 Nektar Therapeutics Al, Corporation Metodo para preparar derivados polimericos solubles en agua que llevan un acido carboxilico terminal.
US7691381B2 (en) * 2004-04-15 2010-04-06 Allergan, Inc. Stabilized biodegradable neurotoxin implants
US20060200048A1 (en) * 2005-03-03 2006-09-07 Icon Medical Corp. Removable sheath for device protection
WO2006110197A2 (en) 2005-03-03 2006-10-19 Icon Medical Corp. Polymer biodegradable medical device
US9107899B2 (en) 2005-03-03 2015-08-18 Icon Medical Corporation Metal alloys for medical devices
US7540995B2 (en) 2005-03-03 2009-06-02 Icon Medical Corp. Process for forming an improved metal alloy stent
US20080114076A1 (en) * 2006-11-09 2008-05-15 Alcon Manufacturing Ltd. Punctal plug comprising a water-insoluble polymeric matrix
AR063621A1 (es) * 2006-11-09 2009-02-04 Alcon Res Ltd Matriz polimerica insoluble en agua para la administracion de farmacos
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
US8398916B2 (en) 2010-03-04 2013-03-19 Icon Medical Corp. Method for forming a tubular medical device
WO2015199816A1 (en) 2014-06-24 2015-12-30 Icon Medical Corp. Improved metal alloys for medical devices
WO2017151548A1 (en) 2016-03-04 2017-09-08 Mirus Llc Stent device for spinal fusion
TWI762706B (zh) 2017-08-24 2022-05-01 丹麥商諾佛 儂迪克股份有限公司 Glp-1組成物及其用途
WO2021144476A1 (en) 2020-02-18 2021-07-22 Novo Nordisk A/S Pharmaceutical formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4010196A (en) * 1975-06-25 1977-03-01 American Home Products Corporation Linear polyester salts
US4268643A (en) * 1979-10-25 1981-05-19 Societa Italiana Resine S.I.R. S.P.A. Process for improving the stability of acetal polymers
US4346709A (en) * 1980-11-10 1982-08-31 Alza Corporation Drug delivery devices comprising erodible polymer and erosion rate modifier
DE3168032D1 (en) * 1980-11-10 1985-02-14 Alza Corp Erodible polymer containing erosion rate modifier
DE3642662A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Parenterale depotzubereitungen von regulatorischen peptiden enthaltend calciumacetat-glycerin-addukt, verfahren zu ihrer herstellung sowie die verwendung des addukts
WO1991003510A1 (en) 1989-08-28 1991-03-21 Pharmaceutical Delivery Systems, Inc. Bioerodible polymers useful for the controlled release of therapeutic agents
US5030457A (en) 1989-08-28 1991-07-09 Pharmaceutical Delivery Systems, Inc. Bioerodible polymers useful for the controlled release of therapeutic agents
WO1993000383A1 (en) 1991-06-20 1993-01-07 Pharmaceutical Delivery Systems, Inc. Pulsed release of high molecular weight therapeutic agents from bioerodible polymer compositions
US5700485A (en) * 1992-09-10 1997-12-23 Children's Medical Center Corporation Prolonged nerve blockade by the combination of local anesthetic and glucocorticoid
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents

Also Published As

Publication number Publication date
AU722303B2 (en) 2000-07-27
DK0885014T3 (da) 2003-02-24
JP4225570B2 (ja) 2009-02-18
KR19990087477A (ko) 1999-12-27
US6440460B1 (en) 2002-08-27
AU2093497A (en) 1997-09-22
PT885014E (pt) 2003-02-28
WO1997032606A1 (en) 1997-09-12
EP0885014A1 (de) 1998-12-23
ATE226450T1 (de) 2002-11-15
AU722303C (en) 2001-12-06
DE69716586T2 (de) 2003-07-17
EP0885014B1 (de) 2002-10-23
KR100441821B1 (ko) 2004-10-15
JP2000506148A (ja) 2000-05-23
ES2185911T3 (es) 2003-05-01

Similar Documents

Publication Publication Date Title
DE69716586D1 (de) Gepufferte orthoesterpolymere enthaltende arzneimittel
AU8009998A (en) Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance
DK0874642T3 (da) Lægemiddelformuleringer med forhalet frigørelse
WO1999007351A3 (en) Indole derivatives and their use as mcp-1 antagonists
IL143063A0 (en) Cross-linked hyaluronic acids and medical uses thereof
MA26456A1 (fr) Formulations pharmaceutiques pour la distribution prolongee de medicament.
EP0815853A3 (de) Langsam freisetzende Zubereitung für bioaktive Substanz mit einer sauren Gruppe
NO2011009I1 (no) Naproksen- og esomeprazoltabletter med modifisert frisetting
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
NO20000284D0 (no) Tanninsyre-polymerblandinger for kontrollert frigivelse av farmasoeytiske midler, saerlig i munnhulen
MY117109A (en) Injectable quinolone formulations.
GR1003658B (el) Δισκιο μητρας που καθιστα δυνατη την παρατεταμενη απελευθερωση της τριμεταζιδινης μετα χορηγηση δια της στοματικης οδου
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
IS4996A (is) Lyfjafræðilegar örkúlur með valprósýru til inngjafar um munn
ATE442852T1 (de) Trimetazidine enthaltendes arzneimittel mit verzögerter wirkstoffabgabe und verfahren zur herstellung
CA2231176A1 (en) Long active composition for rectal administration
AU2773597A (en) Pharmaceutical compositions for the sustained release of insoluble active principles
EP0799618A3 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
CA2243988A1 (en) Pharmaceutical compositions containing buffered ortho ester polymers
ATE269693T1 (de) Abführmittel und verfahren zu deren herstellung
MX9605633A (es) Composicion farmaceutica, metodo y dispositivo para prevenir o tratar resequedad de los ojos o enfermedad ocasionada por la misma.
JO1881B1 (en) Formula II for multi unit disc calibration

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee